Richard Vincent – NPSA Chair, CEO and Managing Director – Australian Pharmaceutical Industries Limited
Richard has worked in the health industry in key leadership roles for over 20 years, with API, Faulding Healthcare and Mayne.
As CEO, he has overseen the continued growth of the Priceline network, now over 460 stores nationally and the acquisition of Clear Skincare Clinics, with 90 clinics throughout Australia and New Zealand. With more than 1,400 community pharmacies in its stable, API provides support and direction through its retail and health services.
Richard is also the Chair of the National Pharmaceutical Services Association which represents the CSO wholesalers; API, National Pharmacies, Sigma and Symbion.
Brett Barons – NPSA Deputy Chair, CEO – Symbion
Brett is the Deputy Chair of NPSA since August 2020 and was appointed Chief Executive Officer for Symbion in April 2018 and is responsible for the Healthcare division of EBOS. This includes all functions of retail pharmacy wholesale, institutional healthcare and contract logistics across Australia and New Zealand. Prior to this, he was Executive General Manager of Pharmacy from 2011-2018.
Brett’s career in the pharmacy sector began in 2002 and has included executive positions with Symbion in business development, finance, supply chain and strategy. Prior to this, Brett worked with Air New Zealand as Senior Vice President Finance – Customer Service and PricewaterhouseCoopers.
Brett is a Chartered Accountant and holds a Bachelor of Commerce from the University of Adelaide.
Jeff Sells – NPSA Director, Executive General Manager – Retail Pharmacy and Interim CFO – Sigma Healthcare Limited
Jeff joined the Board of the NPSA in February 2022. Jeff rejoined Sigma Healthcare Limited as CFO in August 2010 having previously worked for Sigma as Group Treasurer from 2001 to 2004. In 2016 he moved into the new role of Executive General Manager Strategy and Business Development where he had responsibility for strategy development activities, as well as the strategic and operational leadership for the CHS business. Jeff was appointed Executive General Manager Retail Pharmacy in March 2018.
Vito Borrello – NPSA Director, CEO – National Pharmacies
Vito joined National Pharmacies in 2013 as General Manager Operations, Merchandise and Marketing. In 2019 he was appointed Chief Executive Officer at National Pharmacies.
Prior to National Pharmacies, Vito was the Zone General Manager SA/NT/NWWA at Coles Supermarkets from 2008. He has in excess of 40 years’ experience in the retail sector and health industry.
Robert Tassie – NPSA Director, General Manager – Healthcare Service – Australian Pharmaceutical Industries Limited
Rob Tassie has built extensive experience in healthcare over the past 20 years across multiple industry sectors including retail pharmacy, hospitals, pharmaceuticals, FMCG and manufacturing. He has been responsible for strategic and business development functions, pharmacy services and buying functions, corporate communications and investor relations. He has been with Australian Pharmaceutical Industries since 2006.
Sue Forsyth – NPSA Director, Executive General Manager – Commercial – EBOS Group
Sue was appointed to the NPSA Board in 2021. She has more than 15 years commercial and financial experience across healthcare, food, retail and consumer good sectors.
Sue has had extensive experience in commercial dealings with customers and suppliers, M&A, lead roles to tender and execute distribution services, procurement & and major capital works programs.
Prior to EBOS, Sue was with Lion Pty Ltd for 7 years where she held various Commercial Director roles across Revenue & Pricing, Portfolio Management, Supply Chain and Planning & Strategy.
Sue is a Chartered Accountant who commenced her career at Deloitte.
Gary Woodford – NPSA Director, Corporate Affairs Manager – Sigma Healthcare Limited
Gary joined the Board of the NPSA in September 2017. Gary has a broad range of experience gained from almost 30 years in major Australian companies including Elders IXL, Foster’s Brewing Group, Ansett Airlines, Sigma Pharmaceuticals, Tatts Group, and currently Sigma Healthcare. Previous practical experience includes taxation management and planning, finance planning, advice on mergers and acquisitions and capital raising, and investor relations. Gary’s current role at Sigma Healthcare Limited incorporates investor relations, media relations, Government relations, communications, and included the recent re-branding of Sigma.